Company: INSP
Filing Date: 2025-08-04
Form Type: 10-Q
Source: 0001609550-25-000032
Chunk: 15

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-08-04
Form: 10-Q
Item: Part I, Item 1
Chunk 15
---
June 30,Six Months EndedJune 30,2025202420252024Revenue$217,086 $195,885 $418,403 $359,895 Cost of goods sold34,672 29,843 65,381 54,600 Gross profit182,414 166,042 353,022 305,295 Operating expenses:Research and development26,209 28,859 54,012 57,709 Selling, general and administrative159,521 132,084 303,811 257,705 Total operating expenses185,730 160,943 357,823 315,414 Operating (loss) income(3,316)5,099 (4,801)(10,119)Other (income) expense:Interest and dividend income(4,486)(5,882)(9,552)(11,805)Interest expense4 — 4 — Other expense, net3,498 135 2,920 195 Total other income(984)(5,747)(6,628)(11,610)Income (loss) before income taxes(2,332)10,846 1,827 1,491 Income taxes1,260 1,053 2,427 1,703 Net income (loss)(3,592)9,793 (600)(212)Other comprehensive income (loss):Foreign currency translation gain (loss)191 (39)(109)(173)Unrealized loss on investments(22)(200)(31)(742)Total comprehensive income (loss)$(3,423)$9,554 $(740)$(1,127)Net income (loss) per share:Basic$(0.12)$0.33 $(0.02)$(0.01)Diluted$(0.12)$0.32 $(0.02)$(0.01)Weighted average shares outstanding:Basic29,506,807 29,728,849 29,604,043 29,672,006 Diluted29,506,807 30,408,439 29,604,043 29,672,006 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

6

Table of Contents

Inspire Medical Systems, Inc.

Consolidated Statements of Stockholders' Equity (unaudited)

(in thousands, except share amounts